A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
一项随机、双盲、安慰剂对照的II期研究,旨在评估tasquinimod维持治疗对一线多西他赛化疗有反应或病情稳定的转移性去势抵抗性前列腺癌患者的疗效。
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdx487
Fizazi, K; Ulys, A; Sengeløv, L; Moe, M; Ladoire, S; Thiery-Vuillemin, A; Flechon, A; Guida, A; Bellmunt, J; Climent, M A; Chowdhury, S; Dumez, H; Matouskova, M; Penel, N; Liutkauskiene, S; Stachurski, L; Sternberg, C N; Baton, F; Germann, N; Daugaard, G